 |
Bioartificial liver system utilizing xenogenic hepatocytes in a hollow fiber bioreactor cartridge (BAL) |
|---|---|
| Trade Name | |
| Orphan Indication | Patients with acute liver failure presenting with encephalopathy deteriorating beyond Parson's grade 2 |
| USA Market Approval | USA |
| USA Designation Date | 2002-02-11 00:00:00 |
| Sponsor | Excorp Medical, Inc.;Suite 235, 7200 Hudson Blvd.;Oakdale, Minnesota, 55128 |
